Funds holding Ventyx Biosciences Inc
ISIN US92332V1070 · United States
- Fund holders
- 22
- Of which ETFs
- 9 13 other funds
- Value held
- 51.2M $
- Share of capital
- 5.1 % of 71.4M shares on Nov 3, 2025
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 1,032,629 | 14.4M $ | 0.29 % | 1.45 % | as of Feb 27, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 590,649 | 8.3M $ | 0.13 % | 0.83 % | as of Feb 27, 2026 ↗ |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 575,000 | 8M $ | 0.99 % | 0.81 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 334,851 | 4.7M $ | 0.01 % | 0.47 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 312,931 | 4.4M $ | 0.02 % | 0.44 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 171,667 | 2.4M $ | 0.01 % | 0.24 % | as of Feb 28, 2026 ↗ |
| AltShares Merger Arbitrage ETF AltShares Trust | 151,233 | 2.1M $ | 2.04 % | 0.21 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 120,788 | 1.7M $ | 0.00 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 96,542 | 1.3M $ | 0.06 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 93,642 | 1.3M $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 42,703 | 596.6K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 40,440 | 564.9K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| AB All Market Total Return Portfolio AB PORTFOLIOS | 27,291 | 381.3K $ | 0.09 % | 0.04 % | as of Feb 28, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 26,256 | 366.8K $ | 2.34 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 18,076 | 252.5K $ | 0.50 % | 0.03 % | as of Feb 28, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 12,146 | 169.7K $ | 1.59 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 7,112 | 99.4K $ | 0.08 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 4,982 | 69.6K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,977 | 55.6K $ | 0.07 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,295 | 46K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 1,821 | 25.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 413 | 5.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ProShares Merger ETF ProShares Trust | 2.34 % | as of Feb 28, 2026 ↗ |
| AltShares Merger Arbitrage ETF AltShares Trust | 2.04 % | as of Feb 28, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 1.59 % | as of Feb 28, 2026 ↗ |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 0.99 % | as of Feb 28, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 0.50 % | as of Feb 28, 2026 ↗ |
| BlackRock Event Driven Equity Fund BlackRock Large Cap Series Funds, Inc. | 0.29 % | as of Feb 27, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 0.13 % | as of Feb 27, 2026 ↗ |
| AB All Market Total Return Portfolio AB PORTFOLIOS | 0.09 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.08 % | as of Feb 28, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.07 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 22 | -31 | 3,668,444 | -52.0 % |
| 2026Q1 | 53 | +12 | 7,648,401 | +36.7 % |
| 2025Q4 | 41 | -16 | 5,594,672 | +0.3 % |
| 2025Q3 | 57 | -44 | 5,579,131 | -41.0 % |
| 2025Q2 | 101 | -10 | 9,463,152 | -3.6 % |
| 2025Q1 | 111 | +7 | 9,819,203 | -2.3 % |
| 2024Q4 | 104 | -2 | 10,051,906 | -26.6 % |
| 2024Q3 | 106 | -12 | 13,690,762 | +24.4 % |
| 2024Q2 | 118 | +10 | 11,009,193 | +0.2 % |
| 2024Q1 | 108 | -121 | 10,986,138 | -55.1 % |
| 2023Q4 | 229 | 24,467,612 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| IFP Advisors, Inc | 1,500 | 21K $ | as of Mar 31, 2026 |
Declared shareholders of Ventyx Biosciences Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Affinity Asset Advisors, LLC and 1 other | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
| Glazer Capital, LLC and 1 other | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
| TANG CAPITAL MANAGEMENT, LLC and 5 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Ventyx Biosciences Inc". https://titelia.com/en/stocks/ventyx-biosciences-inc-US92332V1070